Viking Therapeutics Inc (VKTX)

53.68 -1.36 (-2.47%) USD  |  NASDAQ  |  Nov 14, 16:00
53.10 -0.58 (-1.08%) After-Hours: 20:00
More

Viking Therapeutics Cash and Short Term Investments (Quarterly): 930.44M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
September 30, 2024 930.44M
June 30, 2024 942.26M
March 31, 2024 962.98M
December 31, 2023 362.08M
September 30, 2023 376.24M
June 30, 2023 392.92M
March 31, 2023 135.66M
December 31, 2022 155.48M
September 30, 2022 155.02M
June 30, 2022 168.92M
March 31, 2022 184.90M
December 31, 2021 202.10M
September 30, 2021 216.14M
June 30, 2021 228.26M
March 31, 2021 241.68M
December 31, 2020 248.39M
September 30, 2020 255.30M
June 30, 2020 263.00M
March 31, 2020 269.16M
December 31, 2019 275.64M
September 30, 2019 288.07M
Date Value
June 30, 2019 292.64M
March 31, 2019 298.72M
December 31, 2018 301.52M
September 30, 2018 304.16M
June 30, 2018 142.17M
March 31, 2018 77.47M
December 31, 2017 20.58M
September 30, 2017 9.839M
June 30, 2017 12.08M
March 31, 2017 12.31M
December 31, 2016 13.15M
September 30, 2016 14.62M
June 30, 2016 17.20M
March 31, 2016 11.25M
December 31, 2015 14.10M
September 30, 2015 17.49M
June 30, 2015 21.66M
March 31, 2015 0.327M
December 31, 2014 0.7559M
June 30, 2014 0.8915M
March 31, 2014 0.0788M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

135.66M
Minimum
Mar 2023
962.98M
Maximum
Mar 2024
348.33M
Average
251.84M
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Amgen Inc 9.011B
Eli Lilly and Co 3.518B
Pfizer Inc 9.952B
Structure Therapeutics Inc 927.12M
Altimmune Inc 164.91M